A solar collaboration sent one micro-cap into orbit, a meme-asset revenue update added fuel to speculative names, while two stocks reversed hard on fresh dilution overhang concerns.

Demand Shock (Sponsored)
A utility focused digital network was recently placed inside an ETP wrapper.
It trades through standard brokerage accounts and removes the need for wallets, exchanges, or operational complexity.
Unlock the name and symbol of this ETF here
*For standardized returns of the Canary HBR ETF, please visit [HBR ETF - Canary Capital]. Past performance does not guarantee future results.
*The Fund’s investment objectives, risks, charges and expenses should be considered before investing. The prospectus contains this and other important information, and it may be obtained at https://canaryetfs.com/HBR/prospectus/. Read it carefully before investing.
*The Fund is not an investment company registered under the Investment Company Act of 1940 (the “1940 Act”) and therefore is not subject to the same regulatory requirements as mutual funds or traditional ETFs registered under the 1940 Act.
*Investing Involves Significant Risk. The loss of principal is possible. Canary HBR ETF (the "Fund") may not be suitable for all investors. This document does not constitute a recommendation of any investment strategy or product for a particular investor. Investors should consult a financial advisor/financial consultant before making any investment decisions.
*The fund is new with a limited operating history. Digital assets, such as HBR, are a relatively new asset class, and the market for digital assets is subject to rapid changes and uncertainty. Digital assets are largely unregulated and digital asset investments may be more susceptible to fraud and manipulation than more regulated investments.
*HBR is subject to unique and substantial risks, including significant price volatility and lack of liquidity, and theft. The value of an investment in the Fund could decline significantly and without warning, including to zero. HBR is subject to rapid price swings, including as a result of actions and statements by influencers and the media, changes in the supply of and demand for digital assets, and other factors. There is no assurance that HBR will maintain its value over the long-term. The Fund is not actively managed and will not take any actions to take advantage, or mitigate the impacts, of volatility in the price of HBR. An investment in the Fund is not a direct investment in HBR. Investors will not have any rights that HBR holders have and will not have the right to receive any redemption proceeds in HBR. Shares of the Fund are generally bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Only Authorized Participants may trade directly with the Fund and only large blocks of Shares called "creation units." Your brokerage commissions will reduce returns.
*Paralel Distributors LLC serves as the marketing agent. Paralel is unaffiliated with Canary Capital and Native Ads.
*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.

Markets
U.S. stocks rose as chip shares rebounded on dip-buying, helped by strong TSMC earnings, sparking a broader tech recovery. Sentiment also improved after Trump said he has no plan to fire Fed Chair Powell, easing fears over Fed independence.
DJIA [+0.60%]
S&P 500 [+0.26%]
Nasdaq [+0.25%]
Russell 2k [+0.98%]

Market-Moving News
Healthcare
Boston Scientific Drops $14.5B to Reclaim a Market It Once Walked Away From

Boston Scientific (NYSE: BSX) is making one of the most consequential bets in modern medtech, agreeing to acquire Penumbra for $14.5 billion in a deal that reshapes its long-term operating footprint across cardiovascular and neurovascular care.
Boston Scientific exited the neurovascular market more than a decade ago. This move brings it back in one shot, with scale, revenue, and a full commercial engine already running. If you remember how cautious re-entries usually look in medtech, this is the opposite.
Buying Speed Instead of Waiting a Decade
Penumbra gives Boston immediate exposure to stroke intervention, clot removal, and neurovascular therapies that hospitals are prioritizing as populations age and acute-care demand rises.
Instead of rebuilding internally, Boston is buying time, expertise, and market credibility in one transaction.
If you zoom out, this is Boston choosing certainty over patience.
The deal strengthens Boston Scientific’s core cardiovascular franchise while expanding it into adjacent, fast-growing procedures that share physicians, hospitals, and purchasing decisions. That overlap matters. It improves margins, cross-selling, and long-term pricing power.
What This Tells You About the Next Medtech Cycle
This is Boston Scientific signaling that the next era of growth belongs to companies with full platforms, not narrow product wins.
If you track how industry leaders prepare before consolidation waves peak, this is what commitment looks like before the field tightens.

Retail
Amazon Draws a Hard Line as the Saks Deal Turns Into a Fight

Amazon (NASDAQ: AMZN) is escalating its response to Saks Global's bankruptcy, turning what began as a high-profile luxury partnership into a sharp test of capital discipline and partner accountability.
By formally objecting to Saks' proposed bankruptcy financing plan, Amazon is signaling that strategic ambition does not excuse weak governance or creditor disadvantage.
The dispute centers on Amazon's roughly $475 million investment tied to Saks' acquisition of Neiman Marcus.
With Saks now in Chapter 11, Amazon argues that its equity has been wiped out while newer lenders are being structurally protected, a setup the company says is unacceptable.
Luxury Dreams Meet Legal Reality
This partnership was supposed to anchor Amazon deeper into luxury retail, blending Saks' brand cachet with Amazon's logistics, storefront technology, and customer reach. Instead, it has become a reminder that prestige does not protect against balance sheet failure.
If you assumed brand access alone guarantees durable value, this episode breaks that illusion quickly. Amazon is making it clear that luxury
A Message Every Future Partner Will Feel
For companies seeking Amazon as an investor or platform ally, the message is blunt and lasting. Visibility, traffic, and scale come bundled with scrutiny, expectations, and consequences.
If you are watching how power platforms evolve, this is what maturity looks like. Amazon is no longer absorbing partner failure quietly; it is enforcing standards in public.

The Next Big Silver (Sponsored)
The silver market is heating up, and Eric Sprott is making moves.
His latest investment targets a U.S. junior explorer returning to America’s first silver mine, where modern technology meets rich history.
With silver prices climbing past $50/oz., this project has the potential to rewrite the narrative.
Click here to uncover the hidden value in America’s silver past and future!

Digital Advertising
Reddit Runs Into an Advertising Reality Check as Budgets Flow Elsewhere

Reddit (NYSE: RDDT) is encountering a slowdown in advertising demand even as the broader digital ad market shows signs of recovery.
The divergence highlights a growing challenge for the platform as it works to translate engagement strength into consistent commercial traction.
Reddit is seeing more cautious allocation, particularly from small and mid-sized advertisers.
Budgets are increasingly flowing toward platforms with automated buying systems, proven conversion performance, and established pricing power, areas where Reddit remains in development.
Engagement Stays Strong, Ad Momentum Softens
User activity and community engagement on Reddit remain elevated, with brands continuing to view the platform as influential for discovery and early-stage consideration.
However, advertisers are signaling that engagement alone is no longer enough to justify incremental spend.
If you track platform economics, this kind of divergence usually shows up when monetization infrastructure lags audience growth. Agencies also note a shift toward unpaid brand participation.
Companies are increasingly using Reddit communities for visibility and credibility without committing to paid campaigns.
Timing Adds Pressure
Reddit’s commercial partnership with Google is not expected to be revisited until 2027, limiting near-term flexibility for revenue expansion.
As competitors benefit from stronger auction dynamics, Reddit now faces pressure to accelerate the execution of its ad products.
For Reddit, the development marks a key operational moment. The next phase is less about user growth and more about proving it can convert influence into durable advertiser demand.

Want to make sure you never miss our post-market roundup?
Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone right after the closing bell rings.
Email’s great. Texts are faster.

Top Winners and Losers
Springview Holdings [SPHL] $17.39 (+649.57%)
Springview jumped after announcing an MOU with China-based GSO to pilot solar and energy-efficiency solutions in Singapore residential projects, boosting its ESG and growth narrative.
Bonk Inc [BNKK] $3.96 (+42.45%)
Bonk surged after releasing a bullish corporate update showing BONK.fun revenue smashing internal targets, with the company highlighting rapidly rising cash-flow momentum.
BRC Group Holdings, Inc [RILY] $9.50 (+25.99%)
BRC Group rocketed after reporting a major earnings turnaround, swinging to $2.91 EPS from a steep loss last year as capital markets performance surged.

Tryhard Holdings Limited [THH] $7.63 (-76.16%)
TryHard declined further after announcing a $25 million equity purchase agreement yesterday, even as the company revealed plans for a Star Party joint venture expansion in Japan.
Caledonia Mining Corp [CMCL] $26.87 (-17.09%)
Caledonia dropped after upsizing a $125 million convertible notes deal, fueling dilution concerns while the company also guided to lower 2026 gold production with higher costs.
Zenas Biopharma Inc [ZBIO] $19.93 (-11.64%)
Zenas fell after Pomerantz LLP announced it is investigating potential securities-fraud claims, spooking investors with lawsuit overhang risk.


Quiet Accumulation (Sponsored)
Liquidity is rising as the Fed shifts toward easier monetary policy.
Institutional capital continues flowing into crypto at record levels, while a pro-crypto administration accelerates favorable regulation.
Mid-term elections historically reward market-friendly policies—and after months of consolidation, conditions are aligning for a powerful move.
But this is one of the strongest setups seen in years—while prices remain relatively low.
Crypto Revolution reveals a disciplined system for building crypto wealth without gambling, sleepless nights, or chasing every price swing.
Get instant access to the book plus $788 in bonuses now.
© 2026 Boardwalk Flock LLC. All Rights Reserved.
2382 Camino Vida Roble, Suite I Carlsbad, CA 92011, United States
*The advice and strategies contained herein may not be suitable for your situation. You should consult with a professional where appropriate. Readers acknowledge that the authors are not engaging in the rendering of legal, financial, medical, or professional advice. The reader agrees that under no circumstances Boardwalk Flock, LLC is responsible for any losses, direct or indirect, which are incurred as a result of the use of the information contained within this, including, but not limited to, errors, omissions, or inaccuracies.
*Results may not be typical and may vary from person to person. Making money trading digital currencies takes time and hard work. There are inherent risks involved with investing, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk.

Everything Else
Maersk is nudging more ships back through the Suez Canal, which could quietly take the edge off freight rates built on disruption.
Trump sketched out a health care plan as Congress fights over Obamacare subsidies, keeping policy clarity just out of reach.
UBS is closing in on a U.S. national bank charter, turning its American business from visitor status into something more permanent.
Ford is in talks with BYD over hybrid batteries, a reminder that supply chains care less about politics than production.
U.S. stocks climbed after solid bank earnings, proof that markets still like it when the numbers cooperate.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!
Thanks for reading. I'll see you at the next open!
Best Regards,
— Adam G.
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.




